Suppliers / Ngl Fine-Chem

Ngl Fine-Chem

India 285 employees Updated 9 July 2026

Ngl Fine-Chem is a contract manufacturer based in India. It holds 3 valid CEPs across a filed portfolio of 3 molecules. Customs aggregates show $9.9M of exports covering 325 molecules to 37 destinations in 2025.

0
active US DMFs
3
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Mumbai, India Not on file
Palghar, India 3012971586

What they file, and where

Molecule Regulators Docs
Flunixin Meglumine For Veterinary Use EDQM 1
Marbofloxacin For Veterinary Use EDQM 1
Triclabendazole For Veterinary Use EDQM 1

Also appears on these molecule pages

Albendazole contract manufacturing Atovaquone contract manufacturing Ofloxacin contract manufacturing Permethrin contract manufacturing Praziquantel contract manufacturing

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $8.0M 37
2025 Not reported $9.9M 37

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Ngl Fine-Chem comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts